Gaudium IVF IPO Opens February 20th to Raise ₹165 Crore for New Centers

Gaudium IVF aims to raise ₹165 crore from its IPO, with ₹50 crore set aside for opening 19 new IVF centers across India.

The Initial Public Offering (IPO) for Gaudium IVF and Women Health Ltd. commenced on February 20th, aiming to raise ₹165 crore. The company is offering shares within a price band of ₹75 to ₹79 each. This issuance is structured as a combination of a fresh issue and an offer-for-sale (OFS). Early indications from the grey market suggest a modest premium, though bidding activity on day one showed varied investor interest.

Gaudium IVF IPO Day 1: Price band, GMP, Listing timeline — All you need to know - 1

Offering Details and Financial Structure

Gaudium IVF's public offering is divided into two main components:

Gaudium IVF IPO Day 1: Price band, GMP, Listing timeline — All you need to know - 2
  • A fresh issue of 1.14 crore shares, designed to raise approximately ₹90 crore.

  • An offer-for-sale (OFS) involving 95 lakh shares, which is expected to generate around ₹75 crore.

The total fundraising target for the IPO is ₹165 crore. The price for each share has been set between ₹75 and ₹79.

Gaudium IVF IPO Day 1: Price band, GMP, Listing timeline — All you need to know - 3

Timeline and Key Dates

The IPO subscription period is scheduled from February 20th to February 24th. Key dates following the closure of the bidding process are as follows:

Gaudium IVF IPO Day 1: Price band, GMP, Listing timeline — All you need to know - 4
  • Allotment Finalisation: February 25th

  • Refunds (for unsuccessful bidders): February 25th

  • Share Credit to Demat Accounts: February 26th

  • Listing Date: February 27th, with shares expected to trade on both the NSE and BSE.

Grey Market Performance and Listing Expectations

The Grey Market Premium (GMP), an unofficial indicator of demand, has shown a premium of around ₹8.5 per share, equating to roughly an 11% increase over the upper price band. This suggests a potential listing price near ₹87.5 per share. However, recent reports indicate a fall in this premium, potentially linked to subdued bidding and broader market sentiment.

Read More: Sony Closes Bluepoint Games Studio in Texas, Affecting 70 Workers

Company Operations and Fund Utilization

Gaudium IVF, established in March 2015, is a provider of In Vitro Fertilization (IVF) treatments in India. The funds raised through the fresh issue are earmarked for specific growth initiatives. Approximately ₹50 crore is allocated for capital expenditure to establish 19 new IVF centers across the country.

Investor Interest on Day One

Initial bidding on the first day saw participation from High Net Worth Individuals (HNIs) and retail investors. The retail portion of the IPO was subscribed to around 77%, while the Non-Institutional Investor (NII) segment reached a subscription level of 42%.

Anchor Investor Allocation

Prior to the public offering, Gaudium IVF secured ₹49.50 crore from four anchor investors. These investors were allocated 62,65,860 equity shares at the upper price band of ₹79 per share.

Investment Considerations

Retail investors can apply for a minimum of one lot, comprising 189 shares, with the investment at the upper price band amounting to ₹14,931. Minimum investment thresholds are set for Small NIIs and Big NIIs as well, requiring applications for 14 lots (₹2,09,034) and 67 lots (₹10,00,377) respectively.

Read More: NHS England Joint Surgery Delayed for Two Months Due to Bone Cement Shortage

Sources

Frequently Asked Questions

Q: When did the Gaudium IVF IPO open and how much money does it want to raise?
The Gaudium IVF IPO opened on February 20th, 2026. It wants to raise ₹165 crore by selling shares.
Q: What is the price range for the Gaudium IVF IPO shares?
The shares are priced between ₹75 and ₹79 each. Investors can buy shares in lots of 189.
Q: What will Gaudium IVF do with the money from the IPO?
The company plans to use about ₹50 crore to build 19 new IVF centers in India. This will help them grow their services.
Q: When will people know if they got shares and when will the company start trading?
Share allotment will be finalized on February 25th, and shares will be listed on the NSE and BSE on February 27th, 2026.
Q: How did investors react on the first day of the IPO?
On the first day, the retail investor part was subscribed to about 77% and the non-institutional investor part was 42% subscribed. This shows mixed interest from investors.